CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 86 filers reported holding CUREVAC N V in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,857,318 | -14.0% | 3,200,193 | +31.1% | 0.01% | 0.0% |
| Q2 2023 | $25,427,926 | +20.7% | 2,440,300 | -19.3% | 0.01% | +25.0% |
| Q1 2023 | $21,074,513 | +60.3% | 3,023,603 | +38.7% | 0.00% | +33.3% |
| Q4 2022 | $13,149,440 | +601.7% | 2,180,670 | +817.0% | 0.00% | – |
| Q3 2022 | $1,874,000 | -59.8% | 237,816 | -30.7% | 0.00% | -100.0% |
| Q2 2022 | $4,667,000 | -54.6% | 342,930 | -34.6% | 0.00% | -50.0% |
| Q1 2022 | $10,285,000 | +6.6% | 524,500 | +86.5% | 0.00% | 0.0% |
| Q4 2021 | $9,649,000 | -61.3% | 281,232 | -38.4% | 0.00% | -60.0% |
| Q3 2021 | $24,920,000 | -45.9% | 456,231 | -27.3% | 0.01% | -50.0% |
| Q2 2021 | $46,098,000 | +103.1% | 627,346 | +152.8% | 0.01% | +66.7% |
| Q1 2021 | $22,693,000 | +12.6% | 248,122 | -0.2% | 0.01% | +50.0% |
| Q4 2020 | $20,151,000 | +135.4% | 248,554 | +35.2% | 0.00% | +100.0% |
| Q3 2020 | $8,560,000 | – | 183,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $23,300,000 | 17.91% |
| Pinz Capital Management, LP | 40,200 | $547,000 | 0.38% |
| Parametrica Management Ltd | 13,513 | $184,000 | 0.20% |
| MQS Management LLC | 16,176 | $220,000 | 0.15% |
| Quantamental Technologies LLC | 11,552 | $157,000 | 0.07% |
| Ergoteles LLC | 98,100 | $1,335,000 | 0.04% |
| Virtus ETF Advisers LLC | 7,676 | $104,000 | 0.04% |
| Green Alpha Advisors, LLC | 12,247 | $167,000 | 0.04% |
| ETF MANAGERS GROUP, LLC | 53,789 | $746,000 | 0.02% |
| Quantbot Technologies LP | 14,800 | $201,000 | 0.02% |